Crescent Infectious Diseases — 1 certified H-1B filings (FY2024)

1
Filings · FY2024
$300k
Median base · FY2024
Physician/ Infectious Disease Consultant
Top role · 1 all-time
OK
Top state · 1 all-time
FY

Crescent Infectious Diseases filed 1 certified H-1B LCAs in FY2024, with a median base salary of $300k and the middle 50% of offers between $300k and $300k. Across all years it has 1 certified filings since FY2024, most often for Physician/ Infectious Disease Consultant in Oklahoma.

How much does Crescent Infectious Diseases pay H-1B workers?

Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $300k median in FY2024. Base pay only — hover a year for its figures.

$290k$300k$310k’24

How has Crescent Infectious Diseases's H-1B hiring changed by year?

1 certified filings on record (FY2024).

Crescent Infectious Diseases certified H-1B filings and base salary by fiscal year
Fiscal yearFilingsvs prior FYMedian base
FY20241—$300k

What jobs does Crescent Infectious Diseases sponsor for H-1B?

The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.

Crescent Infectious Diseases most-sponsored H-1B job titles with base-salary percentiles
Job titleFilingsMedian base
Physician/ Infectious Disease Consultant1$300k

Where does Crescent Infectious Diseases hire H-1B workers?

Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.

11Certified filings (log scale)
Crescent Infectious Diseases H-1B worksite states
StateFilingsMedian base
OK1$300k

What has Crescent Infectious Diseases filed recently?

Every certified LCA on record for Crescent Infectious Diseases: job title, worksite, prevailing-wage level and the offered base salary.

Crescent Infectious Diseases recent certified H-1B LCA filings
FYJob titleBase salary
2024Physician/ Infectious Disease Consultant$300,000

Common questions about Crescent Infectious Diseases's H-1B filings

How much does Crescent Infectious Diseases pay H-1B workers?
Crescent Infectious Diseases's median certified H-1B base salary is $300k (FY2024), from 1 filings. See the full salary distribution and percentiles above.
How many H-1B workers does Crescent Infectious Diseases sponsor?
Crescent Infectious Diseases has 1 certified H-1B Labor Condition Applications on record (FY2024).
What jobs does Crescent Infectious Diseases sponsor for H-1B?
Crescent Infectious Diseases's most-sponsored H-1B roles include Physician/ Infectious Disease Consultant.
Where does Crescent Infectious Diseases hire H-1B workers?
Crescent Infectious Diseases's top H-1B worksite states are OK.
Does a certified LCA mean an H-1B visa was approved?
No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
What salary do these figures show?
The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
What do prevailing-wage levels I–IV mean?
The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.

Keep exploring

Browse all sponsors →

Calculate your H-1B lottery odds →orCheck out the insights →

Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2024). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →